A Study of TQ-B3525 in Subjects With Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Clinical trial NCT04808570 · TERMINATED
Trial details
- NCT number
- NCT04808570
- Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-05
- Primary completion
- 2023-11-22
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.